Literature DB >> 17721944

In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation.

Ye Zhang1, Erica L Bradshaw-Pierce, Alexandra Delille, Daniel L Gustafson, Thomas J Anchordoquy.   

Abstract

To evaluate the in vivo biodistribution and expression of DOTAP-Chol/DNA complexes (lipoplexes) with different in vitro serum stability, quantitative real-time PCR, in vitro luciferase expression and whole body luminescence imaging were used. In general, less tissue biodistribution, lower luciferase expression and whole body luminescence were observed for DOTAP:Chol (mol/mol 1:4)/DNA lipoplexes which had higher in vitro serum stability as compared to DOTAP:Chol (mol/mol 1:1)/DNA lipoplexes. Plasmid DNA biodistribution and expression were mainly confined to the lungs, and the results suggest that in vitro serum stability may serve as a predictor of transfection in the lung. No correlation between plasmid DNA tissue biodistribution and gene expression was observed by simultaneous determination of the level of plasmid DNA tissue biodistribution and gene expression. While high doses of the formulation possessing increased in vitro serum stability did exhibit reduced entrapment in the lung, no corresponding increase in the plasmid levels of other tissues was observed. However, this formulation did show increased accumulation in tumors that was not further enhanced by PEGylation. c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17721944     DOI: 10.1002/jps.21076

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

1.  Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use.

Authors:  Sherry Y Wu; Lisa N Putral; Mingtao Liang; Hsin-I Chang; Nigel M Davies; Nigel A J McMillan
Journal:  Pharm Res       Date:  2008-11-21       Impact factor: 4.200

2.  The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro.

Authors:  Long Xu; Michael F Wempe; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2011-04

3.  Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

Authors:  Long Xu; Jamie Betker; Hao Yin; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2012-03-09       Impact factor: 9.776

4.  Sustained small interfering RNA delivery by mesoporous silicon particles.

Authors:  Takemi Tanaka; Lingegowda S Mangala; Pablo E Vivas-Mejia; René Nieves-Alicea; Aman P Mann; Edna Mora; Hee-Dong Han; Mian M K Shahzad; Xuewu Liu; Rohan Bhavane; Jianhua Gu; Jean R Fakhoury; Ciro Chiappini; Chunhua Lu; Koji Matsuo; Biana Godin; Rebecca L Stone; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood; Mauro Ferrari
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

5.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

6.  A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol.

Authors:  Matthew G Fete; Jamie L Betker; Richard K Shoemaker; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2019-01

7.  Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

8.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

9.  Questioning the Use of PEGylation for Drug Delivery.

Authors:  Johan J F Verhoef; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

10.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.